CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.567
AS - Asia 12.464
EU - Europa 10.495
SA - Sud America 2.083
AF - Africa 251
Continente sconosciuto - Info sul continente non disponibili 113
OC - Oceania 22
Totale 57.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.851
GB - Regno Unito 4.137
CN - Cina 3.681
SG - Singapore 3.184
HK - Hong Kong 1.743
BR - Brasile 1.631
IT - Italia 1.456
VN - Vietnam 1.371
SE - Svezia 1.063
DE - Germania 849
UA - Ucraina 706
FI - Finlandia 685
BD - Bangladesh 648
RU - Federazione Russa 500
TR - Turchia 455
FR - Francia 382
CA - Canada 356
KR - Corea 354
BG - Bulgaria 267
IN - India 214
AR - Argentina 165
ID - Indonesia 156
MX - Messico 108
JP - Giappone 103
EC - Ecuador 76
IQ - Iraq 76
NL - Olanda 70
ZA - Sudafrica 59
CO - Colombia 58
PL - Polonia 56
PK - Pakistan 50
IL - Israele 48
VE - Venezuela 48
MA - Marocco 45
AT - Austria 44
CR - Costa Rica 44
IE - Irlanda 42
AE - Emirati Arabi Uniti 41
MY - Malesia 40
BE - Belgio 37
ES - Italia 36
PH - Filippine 36
UZ - Uzbekistan 34
SA - Arabia Saudita 32
JM - Giamaica 30
EG - Egitto 28
PR - Porto Rico 27
CL - Cile 26
EU - Europa 25
LT - Lituania 25
DZ - Algeria 23
HN - Honduras 22
PE - Perù 22
TN - Tunisia 22
TT - Trinidad e Tobago 22
UY - Uruguay 22
AZ - Azerbaigian 21
PY - Paraguay 21
SV - El Salvador 21
GT - Guatemala 20
NP - Nepal 20
CZ - Repubblica Ceca 19
JO - Giordania 19
PT - Portogallo 19
SC - Seychelles 19
AU - Australia 17
IR - Iran 17
KE - Kenya 16
TH - Thailandia 16
KZ - Kazakistan 13
NI - Nicaragua 12
OM - Oman 12
QA - Qatar 12
CH - Svizzera 11
DO - Repubblica Dominicana 11
BO - Bolivia 10
PS - Palestinian Territory 10
RO - Romania 10
BB - Barbados 9
LB - Libano 9
LV - Lettonia 9
BY - Bielorussia 8
KG - Kirghizistan 8
EE - Estonia 7
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
ET - Etiopia 6
GP - Guadalupe 6
HU - Ungheria 6
MD - Moldavia 6
RS - Serbia 6
SI - Slovenia 6
AM - Armenia 5
AO - Angola 5
BS - Bahamas 5
GE - Georgia 5
GR - Grecia 5
HR - Croazia 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 57.818
Salva come PNG Salva come JPEG
Città #
Ashburn 3.924
Southend 3.067
Fairfield 2.813
Woodbridge 2.279
Santa Clara 2.141
Singapore 1.960
Hong Kong 1.731
Houston 1.639
Jacksonville 1.550
San Jose 1.333
Hefei 1.303
Ann Arbor 1.133
Chandler 1.096
Seattle 1.030
Cambridge 1.025
Wilmington 1.020
Dearborn 905
Council Bluffs 853
Nyköping 746
London 626
Beijing 600
Ho Chi Minh City 480
The Dalles 448
Los Angeles 433
Modena 426
Helsinki 423
San Diego 345
New York 333
Seoul 328
Hanoi 327
Chicago 275
Princeton 275
Sofia 262
Eugene 250
Columbus 221
Milan 219
Buffalo 216
Izmir 210
Lauterbourg 208
São Paulo 169
Dallas 144
Shanghai 137
Des Moines 125
Moscow 113
Toronto 103
Redwood City 102
Jakarta 93
Phoenix 88
Salt Lake City 83
Falls Church 82
Munich 81
Da Nang 78
Rome 77
North Bergen 74
Tokyo 71
Falkenstein 69
Boardman 65
San Francisco 61
Frankfurt am Main 59
Haiphong 58
Philadelphia 58
Atlanta 54
Norwalk 53
Orem 51
Guangzhou 50
Brooklyn 49
Denver 46
Nanjing 42
Warsaw 42
Dublin 40
Mexico City 40
Miano 39
Montreal 39
Tampa 39
Rio de Janeiro 38
Brasília 37
Belo Horizonte 35
Brussels 35
Kent 35
Nuremberg 34
San José 34
Chennai 33
Elk Grove Village 33
Naples 32
Baghdad 31
Charlotte 30
Johannesburg 30
Quito 30
Curitiba 29
Tashkent 29
Washington 28
Bremen 27
Hounslow 26
Verona 26
Biên Hòa 25
Boston 25
Amsterdam 24
Dongguan 24
Guayaquil 24
Kilburn 24
Totale 41.805
Salva come PNG Salva come JPEG
Nome #
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 467
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 438
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 410
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 405
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 405
BCR/ABL activates mdm2 rnRNA translation via the La antigen 394
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 393
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 381
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 378
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 363
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 357
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 354
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 354
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 346
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 345
Altered expression of G1 specific genes in human malignant myeloid cells. 343
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 338
Suppression of autophagy by BCR/ABL 335
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 335
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 334
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 333
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 329
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 324
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 317
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 314
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 314
Activation of human B-MYB by cyclins. 312
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 311
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 310
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 309
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 308
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 306
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 303
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 303
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 303
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 303
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 300
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 298
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 297
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 295
Cell-cycle-dependent expression of human ornithine decarboxylase. 294
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 292
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 289
Coding sequence and growth regulation of the human vimentin gene. 288
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 288
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 286
Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica 286
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 285
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 285
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 285
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 284
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 282
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 282
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. 282
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 279
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα 278
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. 277
Altered mRNA translation: possible mechanism for CML disease progression. 276
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? 275
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 274
Regulation of microRNA-145 by growth arrest and differentiation. 270
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 269
B-myb alters the response to myeloid precurson cells to G-CSF 267
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 267
Antisense oligonucleotides. 266
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 266
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 264
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 262
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 261
BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2 260
Guidelines for the use and interpretation of assays for monitoring autophagy. 260
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. 259
Targeting CDK6 and BCL2 exploits the "MYB addiction" of Phþ acute lymphoblastic leukemia 259
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 258
Role of p53 in hematopoietic recovery after cytotoxic treatment. 258
B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells 257
Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. 257
C-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: Clinical and experimental findings 256
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 256
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 254
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 253
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. 253
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 253
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcriptional factor PU.1 correlates with negative regulation of the c-myb promoter. 252
Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells 252
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. 252
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 251
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 249
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 249
Leukemia stem cells: Old concepts and new perspectives 249
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 249
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 248
Structural and functional analysis of a growth-regulated gene, the human calcyclin 248
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells. 247
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 247
Self complementary sequences in the heterogeneous nuclear RNA of leukemic cells of the HL 60 promyelocytic cell line. 246
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 245
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 245
Translational regulation by the p210 BCR/ABL oncoprotein 244
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. 244
Totale 29.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 225.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.734 0 0 0 0 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.946 82 126 134 158 502 183 274 187 43 19 53 185
2024/20257.583 210 29 56 482 1.454 1.048 754 441 808 280 838 1.183
2025/202615.965 965 885 1.720 2.086 1.512 1.093 1.876 949 1.336 1.329 1.201 1.013
2026/20276.226 628 1.035 1.887 2.234 442 0 0 0 0 0 0 0
Totale 57.995